Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring.

Oettgen P; Boyle AJ; Schulman SP; Hare JM

doi:10.1161/circulationaha.106.639385

Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring.

Affiliations

1. Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA.
Authors
Oettgen P¹
(1 author)

Circulation, 01 Jul 2006, 114(4):353-358
https://doi.org/10.1161/circulationaha.106.639385 PMID: 16864740

Review

Abstract

No abstract provided.

Full text links

Read article at publisher's site: https://doi.org/10.1161/circulationaha.106.639385

References

Articles referenced by this article (42)

2004 Chartbook on Cardiovascular Lung and Blood Diseases. Bethesda Md: National Heart Lung and Blood Institute; 2004.
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators
N Engl J Med, (3):225-237 2005
MED: 15659722
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes.
Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L
J Clin Invest, (3):407-414 2001
MED: 11489934
Regeneration of the infarcted heart with stem cells derived by nuclear transplantation.
Lanza R, Moore MA, Wakayama T, Perry AC, Shieh JH, Hendrikx J, Leri A, Chimenti S, Monsen A, Nurzynska D, West MD, Kajstura J, Anversa P
Circ Res, (6):820-827 2004
MED: 14764454
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration.
Rafii S, Lyden D
Nat Med, (6):702-712 2003
MED: 12778169
Cardiomyocytes can be generated from marrow stromal cells in vitro.
Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S
J Clin Invest, (5):697-705 1999
MED: 10074487
Mesenchymal stem cells and their potential as cardiac therapeutics.
Pittenger MF, Martin BJ
Circ Res, (1):9-20 2004
MED: 15242981
Myocyte and myogenic stem cell transplantation in the heart.
Dowell JD, Rubart M, Pasumarthi KB, Soonpaa MH, Field LJ
Cardiovasc Res, (2):336-350 2003
MED: 12757868
Isolation and expansion of adult cardiac stem cells from human and murine heart.
Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, Salio M, Battaglia M, Latronico MV, Coletta M, Vivarelli E, Frati L, Cossu G, Giacomello A
Circ Res, (9):911-921 2004
MED: 15472116
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.
Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P
Circulation, (15):1913-1918 2002
MED: 12370212

Show 10 more references (10 of 42)

Citations & impact

Impact metrics

Citations

Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/4804545

Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/4804545

Smart citations by scite.ai
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1161/circulationaha.106.639385

Supporting

Mentioning

Contrasting

Article citations

Localized Sampling Enables Monitoring of Cell State via Inline Electrospray Ionization Mass Spectrometry.
Chilmonczyk MA, Doron G, Kottke PA, Culberson AL, Leguineche K, Guldberg RE, Horwitz EM, Fedorov AG
Biotechnol J, 16(3):e2000277, 12 Oct 2020
Cited by: 4 articles | PMID: 32975016 | PMCID: PMC7940552
Free full text in Europe PMC
The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration.
Carresi C, Scicchitano M, Scarano F, Macrì R, Bosco F, Nucera S, Ruga S, Zito MC, Mollace R, Guarnieri L, Coppoletta AR, Gliozzi M, Musolino V, Maiuolo J, Palma E, Mollace V
Nutrients, 13(1):275, 19 Jan 2021
Cited by: 9 articles | PMID: 33477916 | PMCID: PMC7833367
Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Dynamic mass spectrometry probe for electrospray ionization mass spectrometry monitoring of bioreactors for therapeutic cell manufacturing.
Chilmonczyk MA, Kottke PA, Stevens HY, Guldberg RE, Fedorov AG
Biotechnol Bioeng, 116(1):121-131, 06 Nov 2018
Cited by: 7 articles | PMID: 30199089 | PMCID: PMC6310154
Free full text in Europe PMC
Platelet-Rich Plasma May Offer a New Hope in Suppressed Wound Healing When Compared to Mesenchymal Stem Cells.
Aydin O, Karaca G, Pehlivanli F, Altunkaya C, Uzun H, Özden H, Aydin G, Şahiner İT, Niyaz M, Güler O
J Clin Med, 7(6):E143, 08 Jun 2018
Cited by: 10 articles | PMID: 29890683 | PMCID: PMC6025374
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases.
Goradel NH, Hour FG, Negahdari B, Malekshahi ZV, Hashemzehi M, Masoudifar A, Mirzaei H
J Cell Biochem, 119(1):95-104, 12 Jun 2017
Cited by: 67 articles | PMID: 28543595
Review

Go to all (46) article citations

Funding

Funders who supported this work.

NHLBI NIH HHS (1)

Grant ID: P01-HL-76540
1 publication

Search life-sciences literature (45,105,671 articles, preprints and more)

Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring.

Affiliations

Authors

Abstract

Full text links

References

2004 Chartbook on Cardiovascular Lung and Blood Diseases. Bethesda Md: National Heart Lung and Blood Institute; 2004.

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes.

Regeneration of the infarcted heart with stem cells derived by nuclear transplantation.

Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration.

Cardiomyocytes can be generated from marrow stromal cells in vitro.

Mesenchymal stem cells and their potential as cardiac therapeutics.

Myocyte and myogenic stem cell transplantation in the heart.

Isolation and expansion of adult cardiac stem cells from human and murine heart.

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.

Citations & impact

Impact metrics

Citations of article over time

Alternative metrics

Smart citations by scite.ai
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1161/circulationaha.106.639385

Article citations

Localized Sampling Enables Monitoring of Cell State via Inline Electrospray Ionization Mass Spectrometry.

The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration.

Dynamic mass spectrometry probe for electrospray ionization mass spectrometry monitoring of bioreactors for therapeutic cell manufacturing.

Platelet-Rich Plasma May Offer a New Hope in Suppressed Wound Healing When Compared to Mesenchymal Stem Cells.

Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases.

Similar Articles

Contemplating the bright future of stem cell therapy for cardiovascular disease.

Present and future of stem cells for cardiovascular therapy.

Stem cells as future therapy in cardiology.

[A new philosophy on stem cell trials in cardiovascular diseases: to collect pollen or to be a beekeeper].

Funding

NHLBI NIH HHS (1)

Partnerships & funding

Search life-sciences literature (45,105,671 articles, preprints and more)

Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring.

Author information

Affiliations

Authors

Abstract

Full text links

References

2004 Chartbook on Cardiovascular Lung and Blood Diseases. Bethesda Md: National Heart Lung and Blood Institute; 2004.

Citations & impact

Impact metrics

Citations of article over time

Alternative metrics

Article citations

Similar Articles

Funding

NHLBI NIH HHS (1)﻿

Partnerships & funding

NHLBI NIH HHS (1)